Achieving Efficient Manufacturing and Quality Assurance through Synthetic Cell Therapy Design.

Cell Stem Cell

Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada; CCRM, Toronto, ON M5G 1L5, Canada; The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON M5S 3E1, Canada; Medicine by Design: A Canada First Research Excellence Fund Program, University of Toronto, Toronto, ON M5S 3E1, Canada. Electronic address:

Published: January 2017

New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex cellular systems, ultimately increasing patient access to living therapeutics.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stem.2016.12.003DOI Listing

Publication Analysis

Top Keywords

cell therapy
8
achieving efficient
4
efficient manufacturing
4
manufacturing quality
4
quality assurance
4
assurance synthetic
4
cell
4
synthetic cell
4
therapy design
4
design methods
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!